Skip to Main Content
Skip Nav Destination

Issues

Medical Principles and Practice 2023, Vol. 32, No. 2

Systematic Review

Subject Area: General Medicine
Med Princ Pract (2023) 32 (2): 99–109. https://doi.org/10.1159/000530269
Highlights of the Study

  • Dietary approaches such as low-glycemic diets and caloric restriction have shown improvements in cognitive function.

  • Dietary approaches may have a negative impact on problem-solving in those with comorbid cardiovascular disease.

  • There is contradictory evidence that caloric restriction and diet alone is sufficient for the improvement of the cognitive functions.

Original Paper

Subject Area: General Medicine
Med Princ Pract (2023) 32 (2): 110–116. https://doi.org/10.1159/000529240
Subject Area: General Medicine
Med Princ Pract (2023) 32 (2): 117–125. https://doi.org/10.1159/000530179
Highlights of the Study

  • The recent COVID-19 pandemic has changed the stationary trend to a decreasing trend of mammograms in all age-groups.

  • The pandemic has reversed the increasing trend of breast biopsies and breast cancer diagnosed at stages 0 to II.

  • The pandemic has not influenced the increasing trend of breast cancer diagnosed at stages III and IV.

Med Princ Pract (2023) 32 (2): 126–132. https://doi.org/10.1159/000530525
Highlights of the Study

  • Penicillin remains the drug of choice for group B Streptococcus in Sri Lanka.

  • An increase in resistance to erythromycin and clindamycin with inducible clindamycin resistance was seen for group B Streptococcus.

  • ermTR is the predominant resistance gene responsible for erythromycin and clindamycin resistance, and it is significantly associated with inducible clindamycin resistance phenotype.

Med Princ Pract (2023) 32 (2): 133–142. https://doi.org/10.1159/000530631
Highlights

  • Data regarding the prognostic role of plasma albumin and cholinesterase in the sepsis-3 era is limited.

  • In 239 patients with sepsis and septic shock, cholinesterase was associated with moderate diagnostic accuracy for septic shock and risk of 30-day all-cause mortality.

  • In contrast, albumin did not predict all-cause mortality.

Med Princ Pract (2023) 32 (2): 143–148. https://doi.org/10.1159/000530764
Highlights of the Study

  • Disease-modifying therapies in multiple sclerosis (MS) do not seem to adversely affect the course and outcome of COVID-19.

  • There is no need to withhold these treatments as this could lead to uncontrolled MS.

  • Patients on B-cell-depleting therapies should be closely monitored, though the risk of severity following infection is low.

Letter to the Editor

Subject Area: General Medicine
Med Princ Pract (2023) 32 (2): 149–150. https://doi.org/10.1159/000529792

Letter to the Editor / Reply

Subject Area: General Medicine
Med Princ Pract (2023) 32 (2): 151. https://doi.org/10.1159/000529793

Obituary

Subject Area: General Medicine
Med Princ Pract (2023) 32 (2): 152–154. https://doi.org/10.1159/000530538
Close Modal

or Create an Account

Close Modal
Close Modal